Boston Commerce Limited
₹ 4.68
-9.83%
21 Aug
- close price
About
Incorporated in 1995, Boston Bio Systems
Ltd is in the business of trading in goods
e.g. Medical equipment, testing kits,
instruments etc.[1]
Key Points
- Market Cap ₹ 3.28 Cr.
- Current Price ₹ 4.68
- High / Low ₹ 11.0 / 4.01
- Stock P/E
- Book Value ₹ 7.60
- Dividend Yield 0.00 %
- ROCE 0.11 %
- ROE -10.3 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Stock is trading at 0.62 times its book value
Cons
- Company has low interest coverage ratio.
- Promoter holding is low: 2.14%
- Company has a low return on equity of -6.94% over last 3 years.
- Company's cost of borrowing seems high
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Healthcare Service Provider
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.12 | 0.15 | 0.05 | 0.06 | 1.50 | 0.53 | 0.70 | 0.00 | 0.00 | 0.00 | 0.19 | 0.48 | |
| 0.27 | 0.16 | 0.05 | 0.06 | 1.50 | 0.53 | 0.70 | 0.00 | 0.00 | 0.14 | 0.74 | 0.47 | |
| Operating Profit | -0.15 | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.14 | -0.55 | 0.01 |
| OPM % | -125.00% | -6.67% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -289.47% | 2.08% | |||
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.59 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | -0.15 | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.14 | -0.55 | -0.58 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |||||||
| -0.15 | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.14 | -0.55 | -0.58 | |
| EPS in Rs | -0.21 | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.20 | -0.79 | -0.83 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -11% |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 153% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -5% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -41% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | -4% |
| 3 Years: | -7% |
| Last Year: | -10% |
Balance Sheet
Figures in Rs. Crores
| Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7.00 | 7.00 | 7.00 | 7.00 | 7.00 | 7.00 | 7.00 | 7.00 | 7.00 | 7.00 | 7.00 | 7.00 |
| Reserves | -0.40 | -0.40 | -0.40 | -0.40 | -0.40 | -0.40 | -0.40 | -0.41 | -0.41 | -0.55 | -1.10 | -1.68 |
| 0.14 | 0.12 | 0.12 | 0.12 | 0.87 | 0.87 | 0.87 | 0.87 | 0.87 | 0.87 | 5.44 | 0.96 | |
| 0.00 | -0.01 | -0.01 | -0.01 | 1.46 | 1.90 | 2.60 | 3.11 | 3.11 | 3.25 | 3.57 | 1.09 | |
| Total Liabilities | 6.74 | 6.71 | 6.71 | 6.71 | 8.93 | 9.37 | 10.07 | 10.57 | 10.57 | 10.57 | 14.91 | 7.37 |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 6.74 | 6.71 | 6.71 | 6.71 | 8.93 | 9.37 | 10.07 | 10.57 | 10.57 | 10.57 | 14.91 | 7.37 | |
| Total Assets | 6.74 | 6.71 | 6.71 | 6.71 | 8.93 | 9.37 | 10.07 | 10.57 | 10.57 | 10.57 | 14.91 | 7.37 |
Cash Flows
Figures in Rs. Crores
| Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.00 | 0.00 | 0.00 | 0.97 | -0.03 | -0.02 | 0.13 | 0.00 | 0.00 | 0.00 | -4.59 | 5.12 | |
| 0.00 | 0.00 | 0.00 | -0.91 | 0.00 | 0.00 | -0.08 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| -1.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.58 | -5.08 | |
| Net Cash Flow | 0.00 | 0.00 | 0.00 | 0.06 | -0.03 | -0.02 | 0.05 | 0.00 | 0.00 | 0.00 | -0.01 | 0.04 |
| Free Cash Flow | 1.00 | 0.00 | 0.00 | 0.97 | -0.03 | -0.02 | 0.13 | 0.00 | 0.00 | 0.00 | -4.59 | 5.12 |
| CFO/OP | -667% | 0% | 0% | 835% | 51,200% |
Ratios
Figures in Rs. Crores
| Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0.00 | 0.00 | 0.00 | 0.00 | 362.57 | 1,342.92 | 1,308.79 | 5,532.63 | 0.00 | |||
| Inventory Days | 0.00 | 0.00 | 0.00 | 0.00 | 11.59 | |||||||
| Days Payable | 1,488.97 | |||||||||||
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 362.57 | 1,342.92 | -168.60 | 5,532.63 | 0.00 | |||
| Working Capital Days | -425.83 | -292.00 | -876.00 | 4,745.00 | 226.30 | 661.13 | 453.64 | 10,585.00 | 836.46 | |||
| ROCE % | -2.05% | -0.15% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -1.89% | -5.89% | 0.11% |
Insights
In beta| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| Inventory of goods (Stock of Soil) INR lacs |
|
||
| Number of permanent employees count |
|||
Requires Premium
Requires Premium
Extracted by Screener AI
Documents
Announcements
-
Intimation Regarding Cancellation Of Board Meeting Scheduled To Be Held On Friday, 21St August, 2026
- Board meeting scheduled for 21 August 2026 cancelled; Q1 FY27 results approval postponed.
-
Intimation Of Resignation Of Secretarial Auditor
- M/s Shashank Kumar & Associates resigned as Secretarial Auditor, effective 2 July 2026.
-
Announcement under Regulation 30 (LODR)-Change in Management
- Mrs. Archana Chaitanya Pandya appointed Additional Director, Whole-Time Director and CFO from 14 August 2026.
-
Board Meeting Outcome for Outcome Of The Board Meeting Held On 14Th August, 2026
- Board noted MD and CFO resignations, appointed Archana Pandya, and postponed Q1 FY27 results to 21 Aug 2026.
-
Announcement under Regulation 30 (LODR)-Change in Management
- Managing Director Ghanshyam Gavali and CFO Kunjan Rathod resigned effective 12 August 2026.
Annual reports
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
-
Annual Report 2015
from bse
-
Annual Report 2014
from bse
-
Annual Report 2013
from bse
-
Annual Report 2012
from bse
-
Annual Report 2011
from bse
-
Annual Report 2010
from bse
-
Annual Report 2000
from bse
-
Annual Report 1999
from bse
Business Overview:[1]
BBSL specializes in jobwork for herbal and health-related products for formulation companies. Company also has plans to enter the medical field which includes the sales and servicing of medical equipment